Oruka Therapeutics, Inc. · NASDAQ:ORKA

Fairmount Funds Management LLC reported a 19.99% stake in Oruka Therapeutics, Inc. (Schedule 13D/A)

Event Mar 6, 2025 · Filed Mar 10, 2025

Fairmount Funds Management LLC reported a 19.99% stake in Oruka Therapeutics, Inc., 8,511,824 shares, with active intent on Mar 6, 2025. Filed Mar 10, 2025 (Schedule 13D/A).

Stake
19.99%
Shares
8,511,824
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC19.99%8,511,824
Fairmount Healthcare Fund II L.P.13.95%5,938,516
Fairmount Healthcare Co-Invest III L.P.6.87%2,573,308
Peter Evan Harwin19.99%8,511,824
Tomas Kiselak19.99%8,511,824

Source

View original at SEC

Related